Banco de Sabadell SA:企業の戦略・SWOT・財務情報

◆英語タイトル:Banco de Sabadell SA - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C3977
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Banco de Sabadell SA – Strategy, SWOT and Corporate Finance Report
Summary

Banco de Sabadell SA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Banco de Sabadell SA (Banco Sabadell) is a banking group that provides financial services through its subsidiaries, brands, and part-owned companies. The group offers various services including commercial banking, corporate banking, private banking, investment management, and real-estate asset management. It offers products and services through a network of branches and online and mobile banking channels. The group operates in the US, France, Spain, the UK, Morocco, Algeria, Brazil, China, Colombia, the UAE, India, Peru, Poland, Dominican Republic, Singapore, Turkey, Mexico and Andorra. Banco Sabadell is headquartered in Alicante, Spain.

Scope

- Detailed information on Banco de Sabadell SA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Banco de Sabadell SA in the form of a SWOT analysis
- An in-depth view of the business model of Banco de Sabadell SA including a breakdown and examination of key business segments
- Intelligence on Banco de Sabadell SA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Banco de Sabadell SA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Banco de Sabadell SA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Banco de Sabadell SA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Banco de Sabadell SA’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Banco de Sabadell SA: Company Overview 9
Banco de Sabadell SA: Overview and Key Facts 9
Banco de Sabadell SA: Overview 9
Banco de Sabadell SA: Key Facts 9
Banco de Sabadell SA: Key Employees 11
Banco de Sabadell SA: Key Employee Biographies 13
Banco de Sabadell SA: Major Products and Services 14
Banco de Sabadell SA: Company History 15
Banco de Sabadell SA: Management Statement 19
Banco de Sabadell SA: Locations and Subsidiaries 22
Banco de Sabadell SA: Key Competitors 24
Banco de Sabadell SA: Company Analysis 25
Banco de Sabadell SA: Business Description 25
Banco de Sabadell SA: SWOT Analysis 26
Banco de Sabadell SA: SWOT Overview 26
Banco de Sabadell SA: Strengths 26
Banco de Sabadell SA: Weaknesses 27
Banco de Sabadell SA: Opportunities 27
Banco de Sabadell SA: Threats 27
Banco de Sabadell SA: Corporate Financial Deals Activity 29
Banco de Sabadell SA: Financial Deals Overview 29
Banco de Sabadell SA: Targets and Partners 31
Banco de Sabadell SA: Top Deals 2014 – 2018YTD* 33
Banco de Sabadell SA: Advisors 34
Banco de Sabadell SA: Top Legal Advisors 34
Banco de Sabadell SA: Top Financial Advisors 34
Banco de Sabadell SA: Mergers and Acquisitions 35
Banco de Sabadell SA: Corporate Venturing 36
Banco de Sabadell SA: Divestments 37
Banco de Sabadell SA: Recent Developments 38
Banco de Sabadell SA: News and Events Summary 38
Banco de Sabadell SA: Contracts 41
Banco de Sabadell SA: Corporate Governance 42
Banco de Sabadell SA: Financial Deals 42
Banco de Sabadell SA: Financial Performance 42
Banco de Sabadell SA: Regulatory and Legal Events 43
Banco de Sabadell SA: Strategy and Operations 43
Appendix 45
Contact Us 45
Methodology 45
About MarketLine 46

List of Tables
Table 1: Banco de Sabadell SA: Key Facts
Table 2: Banco de Sabadell SA: Key Employees
Table 3: Banco de Sabadell SA: Locations and Subsidiaries
Table 4: Banco de Sabadell SA: Key Competitors
Table 5: Banco de Sabadell SA: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Banco de Sabadell SA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Banco de Sabadell SA: M&A Average Deal Size - Value (US$m)
Table 8: Banco de Sabadell SA: Targets and Partners
Table 9: Banco de Sabadell SA: Top Deals 2014 - 2018YTD*
Table 10: Banco de Sabadell SA: Legal Advisor Ranking by Value (US$m)
Table 11: Banco de Sabadell SA: Financial Advisor Ranking by Value (US$m)
Table 12: Banco de Sabadell SA: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Banco de Sabadell SA: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Banco de Sabadell SA: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 15: Banco de Sabadell SA: Corporate Venturing by Geography (2014 - YTD*2018)
Table 16: Banco de Sabadell SA: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 17: Banco de Sabadell SA: Divestments by Geography (2014 - YTD*2018)
Table 18: Banco de Sabadell SA: News and Events Summary
Table 19: Banco de Sabadell SA: Contracts
Table 20: Banco de Sabadell SA: Corporate Governance
Table 21: Banco de Sabadell SA: Financial Deals
Table 22: Banco de Sabadell SA: Financial Performance
Table 23: Banco de Sabadell SA: Regulatory and Legal Events
Table 24: Banco de Sabadell SA: Strategy and Operations

List of Figures
Figure 1: Banco de Sabadell SA: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Banco de Sabadell SA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Banco de Sabadell SA: M&A Average Deal Size - Value (US$m)
Figure 4: Banco de Sabadell SA: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Banco de Sabadell SA: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Banco de Sabadell SA: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 7: Banco de Sabadell SA: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 8: Banco de Sabadell SA: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 9: Banco de Sabadell SA: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Banco de Sabadell SA:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • HDR Inc:企業の戦略的SWOT分析
    HDR Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • NGM Biopharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary NGM Biopharmaceuticals Inc (NGM Bio) is a clinical stage biopharmaceutical company which focuses on the development of drug discovery platform to generate biologic drug candidates to treat cardio-metabolic, immuno-oncology and liver diseases. Its product pipeline includes NGM282, NGM386, NGM …
  • Cellumed Co Ltd (049180):医療機器:M&Aディール及び事業提携情報
    Summary Cellumed Co Ltd (Cellumed), formerly Korea Bone Bank Inc is a biotechnology company that develops bone graft substitution based on human tissue graft. The company offers allograft tissue products such as bio-clearant, a clearant process that treats tissues with patented chemicals and sterili …
  • Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196):医療機器:M&Aディール及び事業提携情報
    Summary Shanghai Fosun Pharmaceutical (Group) Co Ltd (Fosun Pharma), a subsidiary of Shanghai Fosun High Technology (Group) Co Ltd is a drug company that offers pharmaceutical products, medical diagnostic products and medical device products. The company’s pharmaceutical products include metabolism …
  • Alcami Corp:企業の戦略的SWOT分析
    Alcami Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Koninklijke Ahold Delhaize NV (AD):企業の財務・戦略的SWOT分析
    Koninklijke Ahold Delhaize NV (AD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Total Energy Services Inc. (TOT):企業の財務・戦略的SWOT分析
    Total Energy Services Inc. (TOT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • 3-D Matrix Ltd (7777):製薬・医療:M&Aディール及び事業提携情報
    Summary 3-D Matrix Ltd (3-D Matrix) is a regenerative medicine company that focuses at commercializing its self-assembling peptide technology. It develops medical products by applying this technology under a license granted by Massachusetts Institute of Technology (MIT). The technology finds applica …
  • Fabric Genomics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Fabric Genomics Inc (Fabric), formerly Omicia Inc, is a healthcare solutions provider that offers genome interpretation solutions. The company offers Opal, a cloud-based informatics platform that helps to analyze and interpret genomes by prioritizing disease-causing variants and genes. Fabri …
  • The Goodyear Tire & Rubber Company:企業の戦略・SWOT・財務分析
    The Goodyear Tire & Rubber Company - Strategy, SWOT and Corporate Finance Report Summary The Goodyear Tire & Rubber Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Clarins SA:企業の戦略・SWOT・財務情報
    Clarins SA - Strategy, SWOT and Corporate Finance Report Summary Clarins SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Program for Appropriate Technology in Health-製薬・医療分野:企業M&A・提携分析
    Summary Program for Appropriate Technology in Health (PATH) is a healthcare organization that offers vaccines, drugs, diagnostics, devices, system and service innovations, and digital health solutions. The organization offers HIV and AIDS, influenza, malaria and tuberculosis care services. It develo …
  • Brake Bros Ltd:企業の戦略的SWOT分析
    Brake Bros Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • OMV New Zealand Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary OMV New Zealand Ltd (OMV NZ) a subsidiary of OMV AG, is an oil and natural gas exploration and production company. It offers upstream production services with offshore oil and gas fields in Maari, Pohokura, and Maui across Taranaki coast, Tunisia and in the Black Sea. The company operates ex …
  • Chiesi Farmaceutici SpA:企業の戦略的SWOT分析
    Chiesi Farmaceutici SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Octapharma AG:企業の戦略的SWOT分析
    Octapharma AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Medical Prognosis Institute AS (MPI):医療機器:M&Aディール及び事業提携情報
    Summary Medical Prognosis Institute A/S (MPI) is a precision medicine provider that offers cancer treatment solutions. The company offers drug response prediction platforms that provide tools for rationalized drug development and personalized medicine. It offers lead compound selection, drug rescue …
  • KCC Corp (002380):企業の財務・戦略的SWOT分析
    KCC Corp (002380) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • China Cinda Asset Management Co Ltd:企業のM&A・事業提携・投資動向
    China Cinda Asset Management Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Cinda Asset Management Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on …
  • Laerdal Medical AS:企業の戦略的SWOT分析
    Laerdal Medical AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆